EUROIMMUN ELISAs based on recombinant antigens p52 (IgM) and glycoprotein B (IgG) from cytomegalovirus (CMV) provided a higher rate of conclusive results in first-line testing of samples from pregnant women than lysate-based assays. A recombinant testing strategy could thus help to reduce the number of analyses required for routine CMV screening during pregnancy. These are […]

EUROIMMUN ELISAs for detection of antibodies against Crimean-Congo haemorrhagic fever virus (CCHFV) reliably identify acute CCHF cases and are suitable for laboratories involved in on-site outbreak support. This was demonstrated in a recently published study in collaboration with scientists at a national reference laboratory in Turkey. Crimean-Congo haemorrhagic fever (CCHF) is a life-threatening tick-borne disease